Azita Saleki-Gerhardt
Chief Operating Officer bei ABBVIE INC.
Vermögen: 44 Mio $ am 31.03.2024
Aktive Positionen von Azita Saleki-Gerhardt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ENTEGRIS, INC. | Director/Board Member | 14.08.2017 | - |
Independent Dir/Board Member | 14.08.2017 | - | |
ABBVIE INC. | Chief Operating Officer | 01.07.2023 | - |
Corporate Officer/Principal | 29.06.2023 | 01.07.2023 | |
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Chairman | - | - |
United Way of Lake County | Director/Board Member | - | - |
Karriereverlauf von Azita Saleki-Gerhardt
Ehemalige bekannte Positionen von Azita Saleki-Gerhardt
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ABBOTT LABORATORIES | Corporate Officer/Principal | 01.01.2004 | 01.01.2012 |
Ausbildung von Azita Saleki-Gerhardt
University of Wisconsin | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Deutschland | 2 |
Operativ
Corporate Officer/Principal | 2 |
Director/Board Member | 2 |
Independent Dir/Board Member | 1 |
Sektoral
Health Technology | 4 |
Producer Manufacturing | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
ABBOTT LABORATORIES | Health Technology |
ENTEGRIS, INC. | Producer Manufacturing |
ABBVIE INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
United Way of Lake County | |
AbbVie Deutschland GmbH & Co. KG
AbbVie Deutschland GmbH & Co. KG BiotechnologyHealth Technology Part of AbbVie, Inc., AbbVie Deutschland GmbH & Co. KG is a German company that focuses on treating plaque psoriasis, a chronic inflammatory skin disease that cannot be cured but can be managed effectively. The private company is based in Wiesbaden, Germany. The CEOs of the company are Thomas Scheidmeir, Stefan Simianer. | Health Technology |
- Börse
- Insiders
- Azita Saleki-Gerhardt
- Erfahrung